Authors:
Shahripour, AB
Plummer, MS
Lunney, EA
Sawyer, TK
Stankovic, CJ
Connolly, MK
Rubin, JR
Walker, NPC
Brady, KD
Allen, HJ
Talanian, RV
Wong, WW
Humblet, C
Citation: Ab. Shahripour et al., Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamide, BIOORG MED, 11(20), 2001, pp. 2779-2782
Authors:
Denis, G
Mandard, S
Humblet, C
Verlaet, M
Boniver, J
Stehelin, D
Defresne, MP
Regnier, D
Citation: G. Denis et al., Nuclear localization of a new c-cbl related protein, CARP 90, during in vivo thymic apoptosis in mice (vol 6, pg 689, 1999), CELL DEAT D, 7(2), 2000, pp. 240-240
Authors:
Fridman, V
Humblet, C
Bonjean, K
Boniver, J
Citation: V. Fridman et al., Assessment of tumor angiogenesis in invasive breast carcinomas: absence ofcorrelation with prognosis and pathological factors, VIRCHOWS AR, 437(6), 2000, pp. 611-617
Authors:
Narasimhan, LS
Rubin, JR
Holland, DR
Plummer, JS
Rapundalo, ST
Edmunds, JE
St-Denis, Y
Siddiqui, MA
Humblet, C
Citation: Ls. Narasimhan et al., Structural basis of the thrombin selectivity of a ligand that contains theconstrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl-piperidin-3-yl)-propanoic acid at P1, J MED CHEM, 43(3), 2000, pp. 361-368
Authors:
Denis, G
Mandard, S
Humblet, C
Verlaet, M
Boniver, J
Stehelin, D
Defresne, MP
Regnier, D
Citation: G. Denis et al., Nuclear localization of a new c-cbl related protein, CARP 90, during in vivo thymic apoptosis in mice, CELL DEAT D, 6(7), 1999, pp. 689-697
Authors:
Prasad, JVNV
Boyer, FE
Domagala, JM
Ellsworth, EL
Gajda, C
Hamilton, HW
Hagen, SE
Markoski, LJ
Steinbaugh, BA
Tait, BD
Humblet, C
Lunney, EA
Pavlovsky, A
Rubin, JR
Ferguson, D
Graham, N
Holler, T
Hupe, D
Nouhan, C
Tummino, PJ
Urumov, A
Zeikus, E
Zeikus, G
Gracheck, SJ
Saunders, JM
VanderRoest, S
Brodfuehrer, J
Iyer, K
Sinz, M
Gulnik, SV
Erickson, JW
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor, BIO MED CH, 7(12), 1999, pp. 2775-2800
Authors:
Pavlovsky, AG
Williams, MG
Ye, QZ
Ortwine, DF
Purchase, CF
White, AD
Dhanaraj, V
Roth, BD
Johnson, LL
Hupe, D
Humblet, C
Blundell, TL
Citation: Ag. Pavlovsky et al., X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity, PROTEIN SCI, 8(7), 1999, pp. 1455-1462
Authors:
Dhanaraj, V
Williams, MG
Ye, QZ
Molina, F
Johnson, LL
Ortwine, DF
Pavlovsky, A
Rubin, JR
Skeean, RW
White, AD
Humblet, C
Hupe, DJ
Blundell, TL
Citation: V. Dhanaraj et al., X-ray structure of gelatinase A catalytic domain complexed with a hydroxamate inhibitor, CROAT CHEM, 72(2-3), 1999, pp. 575-591
Authors:
Parker, MH
Lunney, EA
Ortwine, DF
Pavlovsky, AG
Humblet, C
Brouillette, CG
Citation: Mh. Parker et al., Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry, BIOCHEM, 38(41), 1999, pp. 13592-13601
Authors:
Denis, G
Humblet, C
Verlaet, M
Boniver, J
Defresne, MP
Citation: G. Denis et al., p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments, ANTICANC R, 18(5A), 1998, pp. 3315-3321
Authors:
Humblet, C
Denis, G
Greimers, R
Boniver, J
Defresne, MP
Citation: C. Humblet et al., Apoptosis during the development of radiogenic thymic lymphomas: Effects of treatments inhibiting lymphoma development, ANTICANC R, 18(5A), 1998, pp. 3469-3474